SUMMARY Fresh sera and concentrated urine from 17 patients with primary Sjogren's syndrome (SS) were fractionated by high-resolution agarose electrophoresis to investigate the presence of monoclonal immunoglobulins or their components. Homogeneous protein bands were found in the gamma-globulin region in 47% of serum samples and 76% of urine specimens of all patients tested. These monoclonal proteins were detected more often in patients with extraglandular SS (77% in serum, 100% in the urine) than in patients with glandular SS (14% in serum, 43% in the urine). Immunofixation electrophoresis showed that the majority of these monoclonal proteins were free kappa or lambda light chains. Fractionation of unconcentrated parotid salivas from five SS patients failed to reveal the presence of monoclonal light chains or immunoglobulins. The present findings further substantiate our previous observation that a monoclonal process coexists with the polyclonal activation in SS patients.
The immunological hallmark of this syndrome is a polyclonal B cell hyperactivity, which is expressed by hypergammaglobulinaemia, a plethora of organ or non-organ specific autoantibodies, and immune complexes.' Using high-resolution electrophoresis combined with immunofixation electrophoresis we have recently shown that SS patients have a high incidence of circulating monoclonal free light chains in the serum. This finding suggests that the monoclonal process starts early in a subset of B lympho-cytes, long before the expression of the B lymphocyte neoplasm. 4 In this report we extend this observation by demonstrating and identifying monoclonal proteins in the urine of SS patients.
Materials and methods
Pairs of fresh sera and urine were collected from 17 Greek patients with primary SS.5 Serum and urine were also collected from 10 normal age, race, and sex matched controls. All these patients satisfied the criteria for the diagnosis of primary Sjogren (Tables 1 and 2 ). In the extraglandular SS, bands were found in 7/10 (70%) sera, and in all urine specimens tested. In the majority of these sera and urine samples more than one homogeneous protein band was found (Table 1 ). An example of these homogeneous protein bands is shown in the urine electrophoresis patterns in Fig. 1 . In contrast, bands were found in 1/7 (14%) sera and in 3/7 (43%) of the urine specimens tested from patients with (Tables I and 2 ). In the sera and urine of this patient group only one protein band was detected.
Immunofixation electrophoresis studies were performed on 10 sera and the corresponding urine samples which contained monoclonal bands, as well as on three sera without monoclonal proteins. We could identify the monoclonal proteins only in the sera which, in the high-resolution electrophoresis, showed monoclonal bands. In eight sera and urine specimens tested the homogeneous protein bands consisted of free lambda or kappa light chains (Table 1 , Fig. 1 ). One patient showed monoclonal IgM lambda in serum and free monoclonal lambda light chains in urine, while another patient showed monoclonal IgG kappa and monoclonal IgA kappa in the serum. In the urine only monoclonal kappa chains were present ( Table 1 ). The electrophoresis pattern of the urine specimens from normal controls revealed only a small amount of albumin (Fig. 1A) . Electrophoresis of saliva revealed in all specimens tested a single homogeneous band near the point of application (Fig. 2) . Immunofixation electrophoresis failed to demonstrate the presence of immunoglobulins or free light chains.
Discussion
Homogeneous protein bands that extend over a very narrow region of the gamma-globulin area have been clearly shown to be monoclonal immunoglobulins; these bands have been reported to occur in approximately 1% of the normal population.9 Using a very sensitive, high-resolution electrophoretic technique we demonstrated in 5% of sera from healthy National Institutes of Health employees monoclonal protein bands in the gamma-globulin region."' Subsequently similar immunoglobulin bands were found in the sera of 57% of undifferentiated lymphoma patients and 60% of Sjogren's syndrome patients.4 " In none of these patients was one band demonstrated by routine agarose gel protein electrophoresis. These observations indicate that our high-resolution electrophoresis is more sensitive than routinely used techniques, an indication borne out by direct comparison.
In the present study it was reconfirmed that SS patients with multiorgan disease are those who had the high incidence of monoclonal light chains in the serum. Since SS patients with extraglandular manifestations are those who have a higher risk of developing lymphoma, the detection of monoclonal light chains in SS patients may be an early marker of malignant transformation. Prospective serial studies will be necessary to test the validity of this hypothesis.
In this group of patients, who were all Greeks. kappa or lambda monoclonal light chains were demonstrated. This finding is in contrast to our previous observation in American SS patients, where the bands all consisted of free lambda light chains. The discrepancy between our previous study and the present one may be attributed to the different ethnic groups tested. Similar differences were observed in the monoclonal immunoglobulins found in lymphoma cells or in serum of SS patients from different ethnic groups. A study of North American SS patients with lymphoma revealed that the monoclonal lymphoid cells contained in their cytoplasm IgM kappa immunoglobulins.12 Another study from Mexico showed that the monoclonal protein in SS patients with lymphoma showed IgM lambda monoclonal immunoglobulin.13 Finally, a study from Japan showed that sera from SS patients revealed IgA or IgG monoclonal immunoglobulins. 14 Another observation made in this study was the higher recovery of monoclonal proteins in the urine of SS patients compared with serum. In addition it was shown in SS patients that the monoclonal protein, which was identified in the serum, could be recovered from the urine. This finding further substantiates that the monoclonal B lymphocyte process exists together with the polyclonal B lymphocyte hyperactivity in SS patients. 4 Furthermore the high incidence of monoclonal proteins in the urine of SS patients makes the urine an excellent source of antigenic material for preparing antibodies useful for both diagnosis and treatment. We were unsuccessful in demonstrating monoclonal light chains in the saliva of the patients tested. This can be attributed to the fact that the saliva was fractionated unconcentrated.
Finally, it was shown that the sera or urine from SS patients can have more than one monoclonal protein bands. These monoclonal bands were identified by immunofixation electrophoresis as being the same monoclonal light chain. This finding suggests that perhaps slightly altered monoclonal light chains of the same type, or fragments of the same light chain, are present in SS patients. Alternatively this finding may be attributed to the binding of the same light chain to different proteins which migrate in the gamma-globulin region. All these hypotheses are under investigation. 
